Citations for
1FPLCA, OSMR
A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.
Saeedi M, Ebrahim-Habibi A, Haghighi A, Zarrabi F, Amoli MM, Robati RM.
Biomed Res Int 2014:653724. doi: 10.1155/2014/653724. Epub 2014 Jun 26. 2014
2FPLCA, OSMR
The molecular skin pathology of familial primary localized cutaneous amyloidosis.
Tanaka A, Lai-Cheong JE, van den Akker PC, Nagy N, Millington G, Diercks GF, van Voorst Vader PC, Clements SE, Almaani N, Techanukul T, Hide M, South AP, McGrath JA.
Exp Dermatol 19(5):416-23. doi: 10.1111/j.1600-0625.2010.01083.x. 2010
3FPLCA, OSMR
Oncostatin M Receptor-beta Mutations Underlie Familial Primary Localized Cutaneous Amyloidosis.
Arita K, South AP, Hans-Filho G, Sakuma TH, Lai-Cheong J, Clements S, Odashiro M, Odashiro DN, Hans-Neto G, Hans NR, Holder MV, Bhogal BS, Hartshorne ST, Akiyama M, Shimizu H, McGrath JA.
Am J Hum Genet 82(1):73-80. 2008
4FPLCA
Genome-wide scan identifies a susceptibility locus for familial primary cutaneous amyloidosis on chromosome 5p13.1-q11.2.
Lee DD, Lin MW, Chen IC, Huang CY, Liu MT, Wang CR, Chang YT, Liu HN, Liu TT, Wong CK, Tsai SF.
Br J Dermatol 155(6):1201-8. 2006